Skip to main content
logo
Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.660
-0.070 (-2.56%)
Jul 11, 2025, 1:41 PM - Market open

Atai Life Sciences Revenue

Atai Life Sciences had revenue of $1.56M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $1.86M, up 572.56% year-over-year. In the year 2024, Atai Life Sciences had annual revenue of $308.00K, down -1.91%.

Revenue (ttm)
$1.86M
Revenue Growth
+572.56%
P/S Ratio
241.08
Revenue / Employee
$34,500
Employees
54
Market Cap
564.30M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 308.00K -6.00K -1.91%
Dec 31, 2023 314.00K 81.00K 34.76%
Dec 31, 2022 233.00K -20.14M -98.86%
Dec 31, 2021 20.38M - -
Dec 31, 2020 - - -
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

ATAI News

More News